Skip to main content
Top
Published in: Breast Cancer 1/2002

01-01-2002 | Original Article

Concordance in pathological response to neoadjuvant chemotherapy between invasive and noninvasive components of primary breast carcinomas

Authors: Kaneyuki Matsuo, Takashi Fukutomi, Toru Watanabe, Tadashi Hasegawa, Hitoshi Tsuda, Sadako Akashi-Tanaka

Published in: Breast Cancer | Issue 1/2002

Login to get access
Metadata
Title
Concordance in pathological response to neoadjuvant chemotherapy between invasive and noninvasive components of primary breast carcinomas
Authors
Kaneyuki Matsuo
Takashi Fukutomi
Toru Watanabe
Tadashi Hasegawa
Hitoshi Tsuda
Sadako Akashi-Tanaka
Publication date
01-01-2002
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 1/2002
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02967551

Other articles of this Issue 1/2002

Breast Cancer 1/2002 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine